This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
FTI Consulting (FCN) Hires Senior MD for Transactions Practice
by Zacks Equity Research
FTI Consulting (FCN) welcomes Cedric Burgher to the position of senior managing director in its Transactions practice within the Corporate Finance & Restructuring segment.
Reasons to Retain Rollins (ROL) Stock in Your Portfolio
by Zacks Equity Research
Rollins (ROL) is currently benefiting from its balanced approach to organic and inorganic growth.
Zacks.com featured highlights include: Accenture plc, Builders FirstSource, Inc. and AMN Healthcare Services, Inc.
by Zacks Equity Research
Accenture plc, Builders FirstSource, Inc. and AMN Healthcare Services, Inc. are included in this blog.
Charles River (CRAI) Announces Name of New VP in Oakland
by Zacks Equity Research
Charles River (CRAI) welcomes Elizabeth Bailey to the position of vice president of its Antitrust & Competition Economics Practice in Oakland.
3 Stocks With Momentum Anomaly to Create a Winning Portfolio
by Zacks Equity Research
Accenture (ACN), Builders FirstSource (BLDR) and AMN Healthcare Services (AMN) are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
Reasons to Add Republic Services (RSG) Stock to Your Portfolio
by Zacks Equity Research
Republic Services (RSG) continues to focus on its strategic priority of increasing customers' loyalty and their willingness to pay for higher-value services.
IQVIA Holdings (IQV) Stock Up 34.4% In a Year: Here's Why
by Zacks Equity Research
Consecutive better-than-expected top- and bottom-line performances and shareholder-friendly moves have been aiding IQVIA Holdings (IQV) stock.
Five Reasons to Add Genpact (G) Stock in Your Portfolio Now
by Zacks Equity Research
Solid cash balance, investor-friendly steps and artificial intelligence boost Genpact (G).
Should iShares MSCI USA Min Vol Factor ETF (USMV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for USMV
5 Reasons Why You Should Invest in S&P Global (SPGI) Stock
by Zacks Equity Research
Acquisitions enable S&P Global (SPGI) to innovate, increase differentiated content and develop new products.
Reasons to Hold on to ICF International (ICFI) Stock For Now
by Zacks Equity Research
ICF (ICFI) continues to witness revenue growth from government and commercial energy clients.
Best Momentum Stocks to Buy for January 10th
by Zacks Equity Research
MCB, RGP, and ACN made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 10, 2022
New Strong Buy Stocks for January 10th
by Zacks Equity Research
COWN, TGS, VCTR, ACN, and BBWI have been added to the Zacks Rank #1 (Strong Buy) List on January 10, 2022.
3 Reasons Why Growth Investors Shouldn't Overlook Accenture (ACN)
by Zacks Equity Research
Accenture (ACN) possesses solid growth attributes, which could help it handily outperform the market.
Are You Looking for a Top Momentum Pick? Why Accenture (ACN) is a Great Choice
by Zacks Equity Research
Does Accenture (ACN) have what it takes to be a top stock pick for momentum investors? Let's find out.
New Strong Buy Stocks for January 5th
by Zacks Equity Research
SUN, MANU, VCTR, FERG, and ACN have been added to the Zacks Rank #1 (Strong Buy) List on January 5, 2022.
Here's Why Investors Should Buy Accenture (ACN) Stock Now
by Zacks Equity Research
Solid cash balance and strategic buyouts are boosting Accenture's (ACN) shares.
5 Reasons to Add Avis Budget Group (CAR) Stock in Your Portfolio
by Zacks Equity Research
Avis Budget (CAR) remains focused on structurally improving its business amid the pandemic through cost discipline and operational efficiencies.
Reasons to Bet on Cross Country Healthcare (CCRN) Stock
by Zacks Equity Research
Cross Country Healthcare (CCRN) is currently benefiting from the pandemic-induced increase in demand for healthcare staffing, investments in headcount and technology.
The Zacks Analyst Blog Highlights: Nvidia, Microsoft and Accenture
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Nvidia, Microsoft and Accenture
3 Blockchain Stocks Poised for Big Returns in 2022
by Aniruddha Ganguly
Here we discuss three stocks - NVIDIA (NVDA), Accenture (ACN) and Microsoft (MSFT) - that are well-poised to gain from the growth opportunities presented by blockchain's growing prominence.
The Zacks Analyst Blog Highlights: Tesla, Costco, Accenture, McDonald's and Advanced Micro Devices
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Tesla, Costco, Accenture, McDonald's and Advanced Micro Devices
5 Stocks With Immense Earnings Growth Prospects in 2022
by Rajani Lohia
Investing in companies with earnings growth potential is the right choice in the current environment. Tesla (TSLA), Costco (COST), Accenture (ACN), McDonald's (MCD) and Advanced Micro Devices (AMD) show strong earnings growth potential.
The Zacks Analyst Blog Highlights: Photronics, Preferred Apartment Communities, Accenture, Broadcom and Jabil
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Photronics, Preferred Apartment Communities, Accenture, Broadcom and Jabil
III or ACN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
III vs. ACN: Which Stock Is the Better Value Option?